| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |